Chinese embassy spokesperson urges U.S. to "show sincerity" and "take concrete actions to create the conditions and atmosphere needed for communication."
The FDA analysts also raised concerns about whether women with medical conditions that should preclude them from taking the pill, primarily breast cancer and undiagnosed vaginal bleeding, would avoid the product.
